Skip to content
healthcare.dev

mesalamine

NDC 70771-1071, mesalamine, tablet, delayed release, from Zydus Lifesciences Limited.

Product NDC
70771-1071
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091640
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1071 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MESALAMINE1.2 g/1

Pharmacologic classes

Aminosalicylate [EPC]; Aminosalicylic Acids [CS]

Package NDCNDC-11Package
70771-1071-170771107101120 TABLET, DELAYED RELEASE in 1 BOTTLE (70771-1071-1)
70771-1071-27077110710234 TABLET, DELAYED RELEASE in 1 BOTTLE (70771-1071-2)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/29c0dd58-d2cf-40fa-bc32-0eab61937331

Use it

Look up 70771-1071 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1071 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70771-1071. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.